Table 3.

Diagnosis and Site of Progression

Diagnosis No. of PatientsPatients Suffering From Progres- sionSite of Progression (any involvement)3-150
Local BM CNS Testes New Site
Burkitt type  266  17  12  3  1  1  
B-ALL  56  6  3  2  1  0  1  
Diffuse large B-cell lymphoma  
 Centroblastic  42  2  
 Immunoblastic  6  0  
 Mediastinal (thymic) B-cell lymphoma  8  1  1  
NHL, not further classified:  
 B-cell  30  1  
 Immunophenotype NA3-151 5  
 
Total  413 27 
Diagnosis No. of PatientsPatients Suffering From Progres- sionSite of Progression (any involvement)3-150
Local BM CNS Testes New Site
Burkitt type  266  17  12  3  1  1  
B-ALL  56  6  3  2  1  0  1  
Diffuse large B-cell lymphoma  
 Centroblastic  42  2  
 Immunoblastic  6  0  
 Mediastinal (thymic) B-cell lymphoma  8  1  1  
NHL, not further classified:  
 B-cell  30  1  
 Immunophenotype NA3-151 5  
 
Total  413 27 
F3-150

Multiple sites can be involved in 1 patient.

F3-151

Abdominal primary and lymphoid origin confirmed by CD45 positivity, cytokeratin negativity.

or Create an Account

Close Modal
Close Modal